<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic</title>
	<atom:link href="http://www.xconomy.com/san-diego/2009/03/24/calixa-passes-key-safety-test-in-clinical-trial-of-new-antibiotic/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/san-diego/2009/03/24/calixa-passes-key-safety-test-in-clinical-trial-of-new-antibiotic/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sun, 22 Nov 2009 23:52:13 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: &#8220;Unveiling&#8221; a Biopharma Company Requires More than a News Release &#171;</title>
		<link>http://www.xconomy.com/san-diego/2009/03/24/calixa-passes-key-safety-test-in-clinical-trial-of-new-antibiotic/comment-page-1/#comment-51597</link>
		<dc:creator>&#8220;Unveiling&#8221; a Biopharma Company Requires More than a News Release &#171;</dc:creator>
		<pubDate>Tue, 24 Mar 2009 16:39:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=17341#comment-51597</guid>
		<description>[...] of this approach were phenomenal.  Not only did we secure profiles with BioWorld Today and Xconomy, we generated genuine interest in the Calixa story from reporters with a wide range of life [...]</description>
		<content:encoded><![CDATA[<p>[...] of this approach were phenomenal.  Not only did we secure profiles with BioWorld Today and Xconomy, we generated genuine interest in the Calixa story from reporters with a wide range of life [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic - Xconomy &#124; domainmacher.com</title>
		<link>http://www.xconomy.com/san-diego/2009/03/24/calixa-passes-key-safety-test-in-clinical-trial-of-new-antibiotic/comment-page-1/#comment-51509</link>
		<dc:creator>Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic - Xconomy &#124; domainmacher.com</dc:creator>
		<pubDate>Tue, 24 Mar 2009 06:54:26 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=17341#comment-51509</guid>
		<description>[...] is the original: Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic - Xconomy iMEGA Sues to Bring Sports Betting to New JerseyRITMO MUNDO Watches- Introduction and HistoryAre [...]</description>
		<content:encoded><![CDATA[<p>[...] is the original: Calixa Passes Key Safety Test in Clinical Trial of New Antibiotic &#8211; Xconomy iMEGA Sues to Bring Sports Betting to New JerseyRITMO MUNDO Watches- Introduction and HistoryAre [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
